BioSenic S.A. (EBR:BIOS)

BioSenic Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Other Revenue	-2.39	0.1	0.34	0.3	0.31
Revenue	-2.39	0.1	0.34	0.3	0.31
Revenue Growth (YoY)	-	-69.64%	13.51%	-5.13%	-
Gross Profit	-2.39	0.1	0.34	0.3	0.31
Selling, General & Admin	1.88	2.77	3.65	1.55	0.57
Research & Development	0.6	2.31	3.93	1.03	0.62
Other Operating Expenses	0.23	0.23	-0.21	0.03	-
Operating Expenses	2.75	5.31	23.47	2.61	1.19
Operating Income	-5.14	-5.21	-23.13	-2.32	-0.88
Interest Expense	-0.97	-1.68	-1.49	-0.24	-0.11
Interest & Investment Income	0.06	0.06	0.06	0	-
Currency Exchange Gain (Loss)	0	0	0	-0	-
Other Non Operating Income (Expenses)	0.11	0.12	-4.47	-0.5	-
Pretax Income	-5.94	-6.71	-29.03	-3.05	-0.98
Income Tax Expense	-	-	-0.01	-	-
Earnings From Continuing Operations	-5.94	-6.71	-29.02	-3.05	-0.98
Minority Interest in Earnings	1.94	1.94	0.24	1.01	-
Net Income	-4	-4.77	-28.78	-2.04	-0.98
Net Income to Common	-4	-4.77	-28.78	-2.04	-0.98
Shares Outstanding (Basic)	432	231	137	120	0
Shares Outstanding (Diluted)	432	231	137	120	0
Shares Change (YoY)	150.43%	68.94%	13.98%	181686.84%	-
EPS (Basic)	-0.01	-0.02	-0.21	-0.02	-14.89
EPS (Diluted)	-0.01	-0.02	-0.21	-0.02	-14.89
Free Cash Flow	-1.82	-2.22	-3.47	-1.92	-1.07
Free Cash Flow Per Share	-0.00	-0.01	-0.03	-0.02	-16.15
Gross Margin	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-5103.92%	-6884.82%	-783.11%	-281.09%
Profit Margin	-	-4674.51%	-8564.88%	-689.53%	-315.38%
Free Cash Flow Margin	-	-2177.45%	-1032.74%	-646.96%	-341.99%
EBITDA	-4.81	-4.92	-22.79	-2.3	-0.86
EBITDA Margin	-	-	-	-	-276.92%
D&A For EBITDA	0.33	0.29	0.34	0.02	0.01
EBIT	-5.14	-5.21	-23.13	-2.32	-0.88
EBIT Margin	-	-	-	-	-281.09%
Revenue as Reported	0.58	3.07	0.54	0.27	0.31

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.